Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4553991000168114 | ravulizumab 300 mg / 3 mL injection, 3 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4554001000168118 | ravulizumab 300 mg/3 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ravulizumab 300 mg/3 mL injection, vial | Is a | ravulizumab | true | Inferred relationship | Some | ||
| ravulizumab 300 mg/3 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| ravulizumab 300 mg/3 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| ravulizumab 300 mg/3 mL injection, vial | has Australian BoSS | ravulizumab | true | Inferred relationship | Some | 709424918 | |
| ravulizumab 300 mg/3 mL injection, vial | has intended active ingredient | ravulizumab | true | Inferred relationship | Some | 709424918 | |
| ravulizumab 300 mg/3 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1751898112 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | Is a | True | ravulizumab 300 mg/3 mL injection, vial | Inferred relationship | Some | |
| ravulizumab 300 mg/3 mL injection, 3 mL vial | has MPUU | True | ravulizumab 300 mg/3 mL injection, vial | Inferred relationship | Some | 1153420766 |
Reference Sets
Medicinal product unit of use reference set
FHIR